Benito, Rocíoa; Lumbreras, Evaa; Abáigar, Maríaa; Gutiérrez, Norma C.b; Delgado, Manuelb; Robledo, Cristinaa; García, Juan L.c; Rodríguez-Vicente, Ana E.a; Cañizo, M. Consuelob; Rivas, Jesús Maria Hernándeza,b
aIBSAL(Institute of Biomedicine of Salamanca), IBMCC (Institute of Molecular and Cellular Biology of Cancer), Center of Cancer Research, University of Salamanca-CSIC
bDepartment of Hematology, University Hospital of Salamanca
cInstitute for the Study of Health Sciences from Castilla y león (IESCYL) and Research Unit, University Hospital of Salamanca, Spain
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.pharmacogeneticsandgenomics.com).
Correspondence to Jesús María Hernández Rivas, MD, PhD, Department of Hematology, University Hospital of Salamanca, Paseo San Vicente, 58-182, 37007 Salamanca, Spain Tel:+34 923 291 384; fax:+34 923 294 624; e-mail: [email protected]
Received June 9, 2011
Accepted January 28, 2012
doi: 10.1097/FPC.0b013e328351f3e9
